Failed thrombolysis in myocardial infarction.
作者信息
Qasim A, Chauhan A, More R S
机构信息
St. Mary's Hospital, Portsmouth, UK.
出版信息
Int J Cardiol. 2000 Aug;75(1):5-14. doi: 10.1016/s0167-5273(00)00282-5.
Abstract
Prompt treatment with thrombolytic therapy in acute myocardial infarction has been proven to reduce infarct size and mortality. However, reperfusion fails to occur in 30-50% of patients, either due to impaired epicardial artery flow or microvascular occlusion, with these patients experiencing a higher morbidity and mortality. We review the diagnosis and management of failed thrombolysis in acute myocardial infarction.
摘要
相似文献
1
Failed thrombolysis in myocardial infarction.
Int J Cardiol. 2000 Aug;75(1):5-14. doi: 10.1016/s0167-5273(00)00282-5.
2
Advances in antithrombotic therapy of acute myocardial infarction.急性心肌梗死抗血栓治疗的进展
Am Heart J. 1999 Aug;138(2 Pt 2):S171-6. doi: 10.1016/s0002-8703(99)70339-x.
3
Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET).新型抗血栓和抗血小板药物的演变：阿昔单抗并发症与水蛭素[及备用阿昔单抗]事件比较试验（CACHET）的起源。
Am J Cardiol. 1998 Oct 22;82(8B):63P-68P. doi: 10.1016/s0002-9149(98)00664-x.
4
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct].用于优化急性心肌梗死溶栓治疗的糖蛋白IIb/IIIa受体阻滞剂
Herz. 2001 Apr;26 Suppl 1:42-5. doi: 10.1007/pl00014031.
5
Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.阿昔单抗在急性心肌梗死伴溶栓失败患者中的安全性和耐受性。
Int J Cardiol. 2003 Dec;92(2-3):265-70. doi: 10.1016/s0167-5273(03)00085-8.
6
[Optimal thrombolysis].
Z Kardiol. 2001 Aug;90(8):591-5. doi: 10.1007/s003920170129.
7
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).经皮冠状动脉血运重建期间，比伐卢定联合计划或临时使用的阿昔单抗与低剂量肝素联合阿昔单抗的比较：阿昔单抗并发症与水蛭素治疗缺血事件试验（CACHET）的结果
Am Heart J. 2002 May;143(5):847-53. doi: 10.1067/mhj.2002.122173.
8
Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.急性心肌梗死患者的溶栓治疗及经皮腔内冠状动脉成形术
Z Kardiol. 2000;89 Suppl 4:IV30-40. doi: 10.1007/s003920070061.
9
Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.疗效提高且出血减少：比伐芦定使获益与风险独特解耦的进一步证据。
Am Heart J. 2002 Feb;143(2):189-92. doi: 10.1067/mhj.2002.120407.
10
Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.急性心肌梗死的联合治疗：纤维蛋白溶解疗法与糖蛋白IIb/IIIa抑制
Am Heart J. 2000 Feb;139(2 Pt 2):S33-7. doi: 10.1067/mhj.2000.104090.
引用本文的文献
1
Optimizing the use of thrombolytics in ST-segment elevation myocardial infarction.优化ST段抬高型心肌梗死中溶栓药物的使用。
Drugs. 2009 Oct 1;69(14):1945-66. doi: 10.2165/11317670-000000000-00000.
Zotero 插件